Intestine-specific deletion of microsomal triglyceride transfer protein increases mortality in aged mice

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Liang, Zhe ^a   Xie, Yan ^b   Dominguez, Jessica A ^c   Breed, Elise R ^a   Yoseph, Benyam P ^a   Burd, Eileen M ^d   Farris, Alton B ^d   Davidson, Nicholas O ^b   Coopersmith, Craig M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MYELOPEROXIDASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA; CARRIER PROTEIN; CHOLESTEROL; CYTOKINE; PEROXIDASE; TRIACYLGLYCEROL;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE DELETION; HISTOGENESIS; INTESTINE; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; INTESTINE VILLUS; JEJUNUM; LUNG PARENCHYMA; MORTALITY; MOUSE; MOUSE STRAIN; MTTP GENE; MTTP IKO MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA; SEPSIS; SURVIVAL TIME; TISSUE LEVEL; TISSUE SPECIFICITY; ANIMAL; ANTIBODY SPECIFICITY; CELL PROLIFERATION; GENE INACTIVATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; LIVER; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPLEEN; SURVIVAL; TRANSPORT AT THE CELLULAR LEVEL;

AGING; ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL PROLIFERATION; CHOLESTEROL; CYTOKINES; GENE KNOCKOUT TECHNIQUES; INTESTINAL MUCOSA; INTESTINES; LIVER; LUNG; MICE; ORGAN SPECIFICITY; PEROXIDASE; PSEUDOMONAS AERUGINOSA; SEPSIS; SPLEEN; SURVIVAL ANALYSIS; TRIGLYCERIDES;

EID: 84904251233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101828     Document Type: Article

References (81)

1. Gaieski DF, Edwards JM, Kallan MJ, Carr BG (2013) Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41: 1167-1174. 10.1097/CCM.0b013e31827c09f8 [doi].
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310. (Pubitemid 32641789)
3. Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. Crit Care Med 34: 15-21. (Pubitemid 43032375)
4. Turnbull IR, Clark AT, Stromberg PE, Dixon DJ, Woolsey CA, et al. (2009) Effects of aging on the immunopathologic response to sepsis. Crit Care Med 37: 1018-1023.
5. Tucsek Z, Gautam T, Sonntag WE, Toth P, Saito H, et al. (2013) Aging exacerbates microvascular endothelial damage induced by circulating factors present in the serum of septic patients. J Gerontol A Biol Sci Med Sci 68: 652-660. gls232 [pii]; 10.1093/gerona/gls232 [doi].
6. Drechsler S, Weixelbaumer K, Raeven P, Jafarmadar M, Khadem A, et al. (2012) Relationship between age/gender-induced survival changes and the magnitude of inflammatory activation and organ dysfunction in post-traumatic sepsis. PLoS ONE 7: e51457. 10.1371/journal.pone.0051457 [doi];PONE-D-12-24896 [pii].
7. Cao Z, Yende S, Kellum JA, Angus DC, Robinson RA (2013) Proteomics Reveals Age-related Differences in the Host Immune Response to Sepsis. J Proteome Res. 10.1021/pr400814s [doi].
8. Opal SM, Girard TD, Ely EW (2005) The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 41 Suppl 7: S504-S512. (Pubitemid 41598312)
9. Yamamoto K, Shimokawa T, Yi H, Isobe K, Kojima T, et al. (2002) Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol 161: 1805-1814. S0002-9440(10)64457-4 [pii].
10. Saito H, Sherwood ER, Varma TK, Evers BM (2003) Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech Ageing Dev 124: 1047-1058. (Pubitemid 37500830)
11. Gomez CR, Karavitis J, Palmer JL, Faunce DE, Ramirez L, et al. (2010) Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediators Inflamm 2010: 475139. 10.1155/2010/475139 [doi].
12. Chen MM, Palmer JL, Plackett TP, Deburghgraeve CR, Kovacs EJ (2014) Age-related differences in the neutrophil response to pulmonary pseudomonas infection. Exp Gerontol. S0531-5565(13)00366-5 [pii]; 10.1016/j.exger.2013.12. 010 [doi].
13. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, et al. (2003) Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock 19: 310-313.
14. Fink MP (2014) Animal models of sepsis. Virulence 5: 143-153. 26083 [pii]; 10.4161/viru.26083 [doi].
15. Ward PA (2012) New approaches to the study of sepsis. EMBO Mol Med 4: 1234-1243. 10.1002/emmm.201201375 [doi].
16. Mittal R, Coopersmith CM (2013) Redefining the gut as the motor of critical illness. Trends Mol Med. S1471-4914(13)00147-0 [pii]; 10.1016/j.molmed.2013.08.004 [doi].
17. Clark JA, Coopersmith CM (2007) Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 28: 384-393. (Pubitemid 47421846)
18. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV (1986) Multiple-organ-failure syndrome. The gastrointestinal tract: the "motor" of MOF. Arch Surg 121: 196-208.
19. Deitch EA (2012) Gut-origin sepsis: evolution of a concept. Surgeon 10: 350-356. S1479-666X(12)00033-9 [pii]; 10.1016/j.surge.2012.03.003 [doi].
20. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM, et al. (2002) Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287: 1716-1721. (Pubitemid 34289225)
21. Coopersmith CM, Chang KC, Swanson PE, Tinsley KW, Stromberg PE, et al. (2002) Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med 30: 195-201. (Pubitemid 34112196)
22. Coopersmith CM, Stromberg PE, Davis CG, Dunne WM, Amiot DM, et al. (2003) Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med 31: 1630-1637. (Pubitemid 36714214)
23. Clark JA, Clark AT, Hotchkiss RS, Buchman TG, Coopersmith CM (2008) Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis. Shock 30: 36-42.
24. Clark JA, Gan H, Samocha AJ, Fox AC, Buchman TG, et al. (2009) Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 297: G471-G479.
25. Dominguez JA, Coopersmith CM (2010) Can we protect the gut in critical illness? The role of growth factors and other novel approaches. Crit Care Clin 26: 549-65, x. S0749-0704(10)00025-4 [pii]; 10.1016/j.ccc.2010.04.005 [doi].
26. Dominguez JA, Samocha AJ, Liang Z, Burd EM, Farris AB, et al. (2013) Inhibition of IKKbeta in Enterocytes Exacerbates Sepsis-Induced Intestinal Injury and Worsens Mortality. Crit Care Med 41: e275-e285. 10.1097/CCM. 0b013e31828a44ed [doi].
27. Fox AC, McConnell KW, Yoseph BP, Breed E, Liang Z, et al. (2012) The endogenous bacteria alter gut epithelial apoptosis and decrease mortality following Pseudomonas aeruginosa pneumonia. Shock 38: 508-514. 10.1097/SHK.0b013e31826e47e8 [doi].
28. Stromberg PE, Woolsey CA, Clark AT, Clark JA, Turnbull IR, et al. (2009) CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J 23: 1817-1825.
29. Yoseph BP, Breed E, Overgaard CE, Ward CJ, Liang Z, et al. (2013) Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis. PLoS ONE 8: e62792. 10.1371/journal.pone.0062792 [doi];PONE-D-13-07625 [pii].
30. Perrone EE, Jung E, Breed E, Dominguez JA, Liang Z, et al. (2012) Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis. Shock 38: 68-75. 10.1097/SHK.0b013e318259abdb [doi].
31. Rupani B, Caputo FJ, Watkins AC, Vega D, Magnotti LJ, et al. (2007) Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 141: 481-489. S0039-6060(06)00710-0 [pii]; 10.1016/j.surg.2006.10.008 [doi].
32. Fink MP (2003) Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 9: 143-151.
33. Fox AC, Robertson CM, Belt B, Clark AT, Chang KC, et al. (2010) Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis. Crit Care Med 38: 886-893. 10.1097/CCM.0b013e3181c8fdb1 [doi].
34. Turnbull IR, Buchman TG, Javadi P, Woolsey CA, Hotchkiss RS, et al. (2004) Age disproportionately increases sepsis-induced apoptosis in the spleen and gut epithelium. Shock 22: 364-368. (Pubitemid 39468977)
35. Vyas D, Robertson CM, Stromberg PE, Martin JR, Dunne WM, et al. (2007) Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine. Histol Histopathol 22: 623-630. (Pubitemid 46647274)
36. Chang M, Alsaigh T, Kistler EB, Schmid-Schonbein GW (2012) Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS ONE 7: e40087. 10.1371/journal.pone.0040087 [doi];PONE-D-12-08417 [pii].
37. Chang M, Kistler EB, Schmid-Schonbein GW (2012) Disruption of the mucosal barrier during gut ischemia allows entry of digestive enzymes into the intestinal wall. Shock 37: 297-305. 10.1097/SHK.0b013e318240b59b [doi].
38. Qin X, Caputo FJ, Xu DZ, Deitch EA (2008) Hydrophobicity of mucosal surface and its relationship to gut barrier function. Shock 29: 372-376. 10.1097/shk.0b013e3181453f4e [doi]; 00024382-200803000-00010 [pii].
39. Lu Q, Xu DZ, Sharpe S, Doucet D, Pisarenko V, et al. (2011) The anatomic sites of disruption of the mucus layer directly correlate with areas of trauma/hemorrhagic shock-induced gut injury. J Trauma 70: 630-635. 10.1097/TA.0b013e3181e1221b [doi].
40. Fishman JE, Levy G, Alli V, Sheth S, Lu Q, et al. (2013) Oxidative modification of the intestinal mucus layer is a critical but unrecognized component of trauma hemorrhagic shock-induced gut barrier failure. Am J Physiol Gastrointest Liver Physiol 304: G57-G63. ajpgi.00170.2012 [pii]; 10.1152/ajpgi.00170.2012 [doi].
41. Chen C, Wang P, Su Q, Wang S, Wang F (2012) Myosin light chain kinase mediates intestinal barrier disruption following burn injury. PLoS ONE 7: e34946. 10.1371/journal.pone.0034946 [doi];PONE-D-11-24867 [pii].
42. Turner JR (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809. nri2653 [pii]; 10.1038/nri2653 [doi].
43. Geng Y, Li J, Wang F, Li Q, Wang X, Sun L, et al. (2013) Epidermal growth factor promotes proliferation and improves restoration after intestinal ischemia-reperfusion injury in rats. Inflammation 36: 670-679. 10.1007/s10753-012-9591-x [doi].
44. Yang J, Radulescu A, Chen CL, Zhang HY, James IO, et al. (2013) Heparin-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis. Surgery 153: 52-62. S0039-6060(12)00168-7 [pii]; 10.1016/j.surg.2012.04.002 [doi].
45. Seal JB, Alverdy JC, Zaborina O, An G (2011) Agent-based dynamic knowledge representation of Pseudomonas aeruginosa virulence activation in the stressed gut: Towards characterizing host-pathogen interactions in gut-derived sepsis. Theor Biol Med Model 8: 33. 1742-4682-8-33 [pii]; 10.1186/1742-4682-8-33 [doi].
46. Fink D, Romanowski K, Valuckaite V, Babrowski T, Kim M, et al. (2011) Pseudomonas aeruginosa potentiates the lethal effect of intestinal ischemia-reperfusion injury: the role of in vivo virulence activation. J Trauma 71: 1575-1582. 10.1097/TA.0b013e31821cb7e5 [doi].
47. Babrowski T, Romanowski K, Fink D, Kim M, Gopalakrishnan V, et al. (2013) The intestinal environment of surgical injury transforms Pseudomonas aeruginosa into a discrete hypervirulent morphotype capable of causing lethal peritonitis. Surgery 153: 36-43. S0039-6060(12)00315-7 [pii]; 10.1016/j.surg.2012.06.022 [doi].
48. Romanowski K, Zaborin A, Valuckaite V, Rolfes RJ, Babrowski T, et al. (2012) Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype. PLoS ONE 7: e30119. 10.1371/journal.pone.0030119 [doi];PONE-D-11-15176 [pii].
49. Deitch EA (2010) Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann N Y Acad Sci 1207 Suppl 1: E103-E111. 10.1111/j.1749-6632.2010.05713.x [doi].
50. Watkins AC, Caputo FJ, Badami C, Barlos D, Xu dZ, et al. (2008) Mesenteric lymph duct ligation attenuates lung injury and neutrophil activation after intraperitoneal injection of endotoxin in rats. J Trauma 64: 126-130. 10.1097/TA.0b013e3181574a8a [doi]; 00005373-200801000-00020 [pii].
51. Sambol JT, Lee MA, Caputo FJ, Kawai K, Badami C, et al. (2009) Mesenteric lymph duct ligation prevents trauma/hemorrhage shock-induced cardiac contractile dysfunction. J Appl Physiol 106: 57-65. 90937.2008 [pii]; 10.1152/japplphysiol.90937.2008 [doi].
52. Fang JF, Shih LY, Yuan KC, Fang KY, Hwang TL, et al. (2010) Proteomic analysis of post-hemorrhagic shock mesenteric lymph. Shock 34: 291-298. 10.1097/SHK.0b013e3181ceef5e [doi].
53. Mittal A, Middleditch M, Ruggiero K, Loveday B, Delahunt B, et al. (2010) Changes in the mesenteric lymph proteome induced by hemorrhagic shock. Shock 34: 140-149. 10.1097/SHK.0b013e3181cd8631 [doi].
54. Peltz ED, Moore EE, Zurawel AA, Jordan JR, Damle SS, et al. (2009) Proteome and system ontology of hemorrhagic shock: exploring early constitutive changes in postshock mesenteric lymph. Surgery 146: 347-357. S0039-6060(09)00260-8 [pii]; 10.1016/j.surg.2009.02.022 [doi].
55. Deitch EA, Qin X, Sheth SU, Tiesi G, Palange D, et al. (2011) Anticoagulants influence the in vitro activity and composition of shock lymph but not its in vivo activity. Shock 36: 177-183. 10.1097/SHK.0b013e3182205c30 [doi].
56. Reino DC, Pisarenko V, Palange D, Doucet D, Bonitz RP, et al. (2011) Trauma hemorrhagic shock-induced lung injury involves a gut-lymph-induced TLR4 pathway in mice. PLoS ONE 6: e14829. 10.1371/journal.pone.0014829 [doi]; 09-PONE-RA-14427R1 [pii].
57. Reino DC, Palange D, Feketeova E, Bonitz RP, Xu dZ, et al. (2012) Activation of toll-like receptor 4 is necessary for trauma hemorrhagic shock-induced gut injury and polymorphonuclear neutrophil priming. Shock 38: 107-114. 10.1097/SHK.0b013e318257123a [doi].
58. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR (2000) The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 20: 663-697.
59. Dominguez JA, Xie Y, Dunne WM, Yoseph BP, Burd EM, et al. (2012) Intestine-specific Mttp deletion decreases mortality and prevents sepsis-induced intestinal injury in a murine model of Pseudomonas aeruginosa pneumonia. PLoS ONE 7: e49159. 10.1371/journal.pone.0049159 [doi];PONE-D-12-07223 [pii].
60. Xie Y, Newberry EP, Young SG, Robine S, Hamilton RL, et al. (2006) Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency. J Biol Chem 281: 4075-4086. (Pubitemid 43847833)
61. Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG (2004) Humane endpoints in shock research. Shock 21: 17-25.
62. Nemzek JA, Hugunin KM, Opp MR (2008) Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp Med 58: 120-128.
63. McConnell KW, McDunn JE, Clark AT, Dunne WM, Dixon DJ, et al. (2010) Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med 38: 223-241. 10.1097/CCM.0b013e3181b4a76b [doi].
64. Dominguez JA, Vithayathil PJ, Khailova L, Lawrance CP, Samocha AJ, et al. (2011) Epidermal growth factor improves survival and prevents intestinal injury in a murine model of pseudomonas aeruginosa pneumonia. Shock 36: 381-389. 10.1097/SHK.0b013e31822793c4 [doi].
65. Xie Y, Kennedy S, Sidhu R, Luo J, Ory DS, et al. (2012) Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein. Arterioscler Thromb Vasc Biol 32: 1624-1631. ATVBAHA.112.246066 [pii]; 10.1161/ATVBAHA.112.246066 [doi].
66. Muraca M, Kohlhaw K, Vilei MT, Ringe B, Bunzendahl H, et al. (1993) Serum bile acids and esterified bilirubin in early detection and differential diagnosis of hepatic dysfunction following orthotopic liver transplantation. J Hepatol 17: 141-145. (Pubitemid 23054477)
67. Hiramatsu M, Hotchkiss RS, Karl IE, Buchman TG (1997) Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 7: 247-253. (Pubitemid 127654275)
68. Williams AE, Chambers RC (2014) The mercurial nature of neutrophils: still an enigma in ARDS? Am J Physiol Lung Cell Mol Physiol 306: L217-L230. ajplung.00311.2013 [pii]; 10.1152/ajplung.00311.2013 [doi].
69. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307: 2526-2533. 1160659 [pii]; 10.1001/jama.2012.5669 [doi].
70. Zhou X, Dai Q, Huang X (2012) Neutrophils in acute lung injury. Front Biosci (Landmark Ed) 17: 2278-2283. 4051 [pii].
71. Badami CD, Senthil M, Caputo FJ, Rupani BJ, Doucet D, et al. (2008) Mesenteric lymph duct ligation improves survival in a lethal shock model. Shock 30: 680-685. 10.1097/SHK.0b013e318173edd1 [doi].
72. Sarin EL, Moore EE, Moore JB, Masuno T, Moore JL, et al. (2004) Systemic neutrophil priming by lipid mediators in post-shock mesenteric lymph exists across species. J Trauma 57: 950-954. 00005373-200411000-00005 [pii].
73. Ott J, Hiesgen C, Mayer K (2011) Lipids in critical care medicine. Prostaglandins Leukot Essent Fatty Acids 85: 267-273. S0952-3278(11)00044-5 [pii]; 10.1016/j.plefa.2011.04.011 [doi].
74. Wu A, Hinds CJ, Thiemermann C (2004) High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21: 210-221.
75. Lanza-Jacoby S, Miller S, Jacob S, Heumann D, Minchenko AG, et al. (2003) Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice. J Endotoxin Res 9: 341-347. (Pubitemid 38035597)
76. Qiu P, Cui X, Barochia A, Li Y, Natanson C, et al. (2011) The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death. Expert Opin Investig Drugs 20: 1555-1564. 10.1517/13543784.2011.623125 [doi].
77. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, et al. 2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166: 1197-1205. (Pubitemid 35222596)
78. Osuchowski MF, Craciun F, Weixelbaumer KM, Duffy ER, Remick DG (2012) Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol 189: 4648-4656. jimmunol.1201806 [pii]; 10.4049/jimmunol.1201806 [doi].
79. Osuchowski MF, Welch K, Siddiqui J, Remick DG (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177: 1967-1974. (Pubitemid 44092537)
80. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, et al. 2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507-3512. 1222878110 [pii]; 10.1073/pnas.1222878110 [doi].
81. Osuchowski MF, Remick DG, Lederer JA, Lang CH, Aasen AO, et al. (2014) Abandon the mouse research ship? Not just yet! Shock 41: 463-475. 10.1097/SHK.0000000000000153 [doi].